Skip to main content
Figure 4 | Critical Care

Figure 4

From: Endogenous plasma activated protein C levels and the effect of enoxaparin and drotrecogin alfa (activated) on markers of coagulation activation and fibrinolysis in pulmonary embolism

Figure 4

Course of Sekisui soluble fibrin, Tinaquant D-dimer, and Iatron FDP-P. Sekisui soluble fibrin, Tinaquant D-dimer, and Iatron FDP-P before the study drug infusion, after 4, 8 and 12 hours, and on days 2, 3, 4, 5 and 6 days for all patients with an initial (0 h) TINAquant D-dimer level of >4 mg/L. Individual initial values were set at 100% to compensate for individual differences in levels. Initiation of anticoagulant therapy results in a drop in all fibrin-related markers, DAA infusion accelerates the decline of the fibrin-related markers.

Back to article page